| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 16, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 22.5 | -2,003 | -1.54% | ✗ | $150.5K |
| Dec 8, 2025 | Dec 10, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 45.0 | -2,000 | -1.51% | ✓ | $148.5K |
| Nov 16, 2025 | Nov 18, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 20.0 | -4,781 | -3.49% | ✗ | $317.4K |
| Aug 16, 2025 | Aug 19, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 22.5 | -4,781 | -3.37% | ✗ | $245.4K |
| Aug 7, 2025 | Aug 11, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 36.3 | -1,000 | -0.70% | ✗ | $45.4K |
| May 16, 2025 | May 20, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 22.5 | -4,780 | -3.24% | ✗ | $161.8K |
| May 2, 2025 | May 6, 2025 | BridgeBio Pharma, Inc. | Chief Accounting Officer | Sell | 36.3 | -1,026 | -0.69% | ✗ | $39.5K |